Click on headlines below to download research

Licence agreement for IONSYS terminated
SymBio Pharmaceuticals | 15/12/2017

The licence agreement between SymBio and The Medicines Company (MDCO) for the exclusive rights to develop the IONSYS (SyB P-1501) pain patch in Japan has…

Licence agreement for IONSYS terminated
SymBio Pharmaceuticals | 14/12/2017

The licence agreement between SymBio and The Medicines Company (MDCO) for the exclusive rights to develop the IONSYS (SyB P-1501) pain patch in Japan has…

New formulations extend Treakisym patent life
SymBio Pharmaceuticals | 02/11/2017

SymBio has substantially increased the value of its Treakisym franchise through in-licensing novel bendamustine formulations from Eagle Pharmaceuticals…